Plus Therapeutics, Inc.(PSTV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PSTV Plus Therapeutics, Inc.

未开盘 12-20 16:00:00 EST

1.09

+0.10

+10.10%

盘后1.05

-0.04-3.67%

18:13 EST

最高1.11	最低0.9714	成交量4.94万
今开1.01	昨收0.9900	日振幅14.00%
总市值642.70万	流通市值565.19万	总股本589.63万
成交额5.21万	换手率0.95%	流通股本518.53万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PSTV","market":"US","secType":"STK","nameCN":"Plus Therapeutics, Inc.","latestPrice":1.09,"timestamp":1734728400000,"preClose":0.99,"halted":0,"volume":49387,"hourTrading":{"tag":"盘后","latestPrice":1.05,"preClose":1.09,"latestTime":"18:13 EST","volume":520,"amount":546,"timestamp":1734736406960},"delay":0,"floatShares":5185255,"shares":5896333,"eps":-3.090557,"marketStatus":"未开盘","marketStatusCode":0,"change":0.1,"latestTime":"12-20 16:00:00 EST","open":1.01,"high":1.11,"low":0.9714,"amount":52080.621306,"amplitude":0.14,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.090557,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"listingDate":1134968400000,"adjPreClose":0.99,"postHourTrading":{"tag":"盘后","latestPrice":1.05,"preClose":1.09,"latestTime":"18:13 EST","volume":520,"amount":546,"timestamp":1734736406960},"volumeRatio":0.44682714460624773},"requestUrl":"/m/hq/s/PSTV","defaultTab":"news","newsList":[{"id":"2492401684","title":"Plus Therapeutics, Inc.盘中异动 早盘急速拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492401684","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492401684?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:03","pubTimestamp":1734707037,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日23时03分，Plus Therapeutics, Inc.股票出现波动，股价大幅拉升5.04%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Humacyte, Inc.、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Aditxt, Inc.较为活跃，换手率分别为2121.05%、100.19%、57.08%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Humacyte, Inc.、Psyence Biomedical Ltd.，振幅分别为84.80%、48.53%、48.37%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122023035795ea9d26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122023035795ea9d26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTVZ","BK4139","PSTV","LENZ"],"gpt_icon":0},{"id":"2492156685","title":"Plus Therapeutics, Inc.盘中异动 股价大跌6.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492156685","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492156685?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:20","pubTimestamp":1734553212,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时20分，Plus Therapeutics, Inc.股票出现波动，股价大幅下挫6.54%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.19%。其相关个股中，Polyrizon Ltd.、Tc Biopharm  Plc C/Wts 10/02/2028 、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3200.93%、668.16%、347.13%，振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为227.62%、138.10%、105.17%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219042012ab8296e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219042012ab8296e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PSTV","PSTVZ","BK4139"],"gpt_icon":0},{"id":"2492896570","title":"Plus Therapeutics, Inc.盘中异动 早盘股价大跌9.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492896570","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492896570?lang=zh_cn&edition=full","pubTime":"2024-12-17 22:43","pubTimestamp":1734446627,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日22时43分，Plus Therapeutics, Inc.股票出现波动，股价大幅跳水9.40%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Portage Biotech Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Jupiter Neurosciences, Inc.涨幅较大，Portage Biotech Inc.、Polyrizon Ltd.、Reviva Pharmaceuticals Holdings, Inc.较为活跃，换手率分别为1517.71%、89.28%、18.86%，振幅较大的相关个股有Portage Biotech Inc.、Briacell Therapeutics Corp C/Wts 24/02/2025、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为46.46%、23.99%、21.57%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217224347ab7f592e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217224347ab7f592e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PSTV","LENZ","PSTVZ"],"gpt_icon":0},{"id":"2492616429","title":"Plus Therapeutics, Inc.盘中异动 早盘股价大跌6.30%报1.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492616429","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492616429?lang=zh_cn&edition=full","pubTime":"2024-12-16 23:53","pubTimestamp":1734364404,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日23时53分，Plus Therapeutics, Inc.股票出现波动，股价大幅下跌6.30%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.72%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216235324984c7304&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216235324984c7304&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTV","PSTVZ","LENZ","BK4139"],"gpt_icon":0},{"id":"2491547843","title":"Plus Therapeutics, Inc.盘中异动 临近收盘股价大跌5.18%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491547843","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491547843?lang=zh_cn&edition=full","pubTime":"2024-12-13 04:47","pubTimestamp":1734036477,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日04时47分，Plus Therapeutics, Inc.股票出现异动，股价急速下挫5.18%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.71%。其相关个股中，Palisade Bio, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为4353.38%、1271.04%、99.06%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Palisade Bio, Inc.、Aptevo Therapeutics Inc.，振幅分别为129.16%、99.29%、95.90%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213044757ab734d1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213044757ab734d1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTV","BK4139","LENZ","PSTVZ"],"gpt_icon":0},{"id":"2489468218","title":"Plus Therapeutics, Inc.盘中异动 股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489468218","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489468218?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:58","pubTimestamp":1733410692,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日22时58分，Plus Therapeutics, Inc.股票出现波动，股价快速上涨5.26%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120522581298e59f7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120522581298e59f7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PSTVZ","PSTV","LENZ"],"gpt_icon":0},{"id":"2488949795","title":"Plus Therapeutics, Inc.盘中异动 早盘股价大涨5.43%报1.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488949795","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488949795?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:55","pubTimestamp":1733237749,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时55分，Plus Therapeutics, Inc.股票出现异动，股价快速上涨5.43%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，Coherus Biosciences, Inc.、Janux Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Nls Pharmaceutics Ltd.、Purple Biotech Ltd、Senti Biosciences, Inc.较为活跃，换手率分别为134.56%、87.66%、80.43%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Coherus Biosciences, Inc.、Senti Biosciences, Inc.，振幅分别为51.13%、48.91%、28.70%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203225549abf30585&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203225549abf30585&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTV","PSTVZ","LENZ","BK4139"],"gpt_icon":0},{"id":"2486054773","title":"Plus Therapeutics, Inc.盘中异动 下午盘股价大涨5.08%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486054773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486054773?lang=zh_cn&edition=full","pubTime":"2024-11-26 03:36","pubTimestamp":1732563410,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日03时36分，Plus Therapeutics, Inc.股票出现波动，股价大幅拉升5.08%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.66%。其相关个股中，Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Exicure, Inc.、Apollomics Inc C/Wts 01/04/2028 涨幅较大，木薯科学、Cognition Therapeutics, Inc.、Exicure, Inc.较为活跃，换手率分别为173.19%、109.37%、104.27%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为95.05%、85.86%、80.00%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126033650971a8731&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126033650971a8731&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTV","PSTVZ","LENZ","BK4139"],"gpt_icon":0},{"id":"2485298082","title":"Plus Therapeutics, Inc.2024财年第三财季实现净利润-2.87百万美元，同比增加10.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485298082","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485298082?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:03","pubTimestamp":1732291430,"startTime":"0","endTime":"0","summary":"11月23日，Plus Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-2.87百万美元，同比增加10.87%；其中营业收入为1.46百万美元，同比增加17.74%，每股基本收益为-0.37美元。从资产负债表来看，Plus Therapeutics, Inc.总负债12.15百万美元，其中短期债务3.36百万美元，资产负债比为0.58，流动比率为0.45。机构评级：截至2024年11月23日，当前有4家机构对Plus Therapeutics, Inc.目标价做出预测，其中目标均价为10.50美元，其中最低目标价为4.00美元，最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000420a24e4a00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000420a24e4a00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTVZ","PSTV","LENZ"],"gpt_icon":0},{"id":"2485262537","title":"Plus Therapeutics, Inc.盘中异动 急速下挫6.25%报1.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485262537","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485262537?lang=zh_cn&edition=full","pubTime":"2024-11-22 23:03","pubTimestamp":1732287797,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日23时03分，Plus Therapeutics, Inc.股票出现波动，股价大幅跳水6.25%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Replimune Group, Inc.、Virpax Pharmaceuticals, Inc.、Exicure, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1413.78%、103.10%、76.25%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Invizyne Technologies Inc.，振幅分别为48.21%、42.36%、33.30%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122230317a24e2f42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122230317a24e2f42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTV","BK4139","PSTVZ","LENZ"],"gpt_icon":0},{"id":"2483023858","title":"Plus Therapeutics, Inc.盘中异动 下午盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483023858","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483023858?lang=zh_cn&edition=full","pubTime":"2024-11-14 02:10","pubTimestamp":1731521414,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日02时10分，Plus Therapeutics, Inc.股票出现波动，股价急速拉升5.04%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为531.64%、389.62%、139.81%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Celularity Inc C/Wts 16/07/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为128.00%、73.71%、71.97%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111402101498e426f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111402101498e426f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PSTVZ","PSTV","LENZ"],"gpt_icon":0},{"id":"2483983370","title":"Plus Therapeutics Inc 预计每股亏损56美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2483983370","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483983370?lang=zh_cn&edition=full","pubTime":"2024-11-13 07:58","pubTimestamp":1731455916,"startTime":"0","endTime":"0","summary":"Plus Therapeutics Inc 预计每股亏损56美分 - 财报前瞻Plus Therapeutics Inc PSTV.OQ PSTV.O预计将在11月14日公布截至2024年9月30日的季度收入报告。LSEG 分析师对 Plus Therapeutics Inc 的平均预期是每股亏损 56 美分。华尔街对 Plus Therapeutics Inc 的 12 个月目标价中位数为 26.00 美元，高于其上次收盘价 1.29 美元。11月12日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nL4S3MJ2OL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSTV"],"gpt_icon":0},{"id":"2482086891","title":"Plus Therapeutics, Inc.盘中异动 早盘股价大涨5.04%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482086891","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482086891?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:32","pubTimestamp":1731421926,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时32分，Plus Therapeutics, Inc.股票出现波动，股价急速拉升5.04%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Klotho Neurosciences Inc C/Wts 21/06/2029 、Cero Therapeutics Holdings, Inc.涨幅较大，Geovax Labs, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为113.25%、68.09%、45.15%，振幅较大的相关个股有Onconetix, Inc.、Geovax Labs, Inc.、Matinas Biopharma Holdings, Inc.，振幅分别为13.13%、11.77%、11.11%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111222320695be1963&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111222320695be1963&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PSTV","LENZ","PSTVZ"],"gpt_icon":0},{"id":"2481102741","title":"Plus Therapeutics, Inc.盘中异动 早盘股价大跌6.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481102741","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481102741?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:44","pubTimestamp":1731077055,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时44分，Plus Therapeutics, Inc.股票出现异动，股价快速跳水6.61%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Matinas Biopharma Holdings, Inc.、Fortrea Holdings Inc.、Inhibikase Therapeutics, Inc.涨幅较大，Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为454.69%、36.39%、19.84%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Inhibikase Therapeutics, Inc.，振幅分别为86.00%、31.72%、29.86%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108224415abae43ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108224415abae43ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTVZ","LENZ","BK4139","PSTV"],"gpt_icon":0},{"id":"2481688207","title":"Plus Therapeutics, Inc.盘中异动 股价大涨6.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481688207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481688207?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:32","pubTimestamp":1730817136,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日22时32分，Plus Therapeutics, Inc.股票出现异动，股价大幅拉升6.61%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110522321695bdd203&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110522321695bdd203&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PSTV","PSTVZ","BK4139"],"gpt_icon":0},{"id":"2480381833","title":"Plus Therapeutics Inc   预计每股亏损56美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480381833","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480381833?lang=zh_cn&edition=full","pubTime":"2024-11-02 11:56","pubTimestamp":1730519810,"startTime":"0","endTime":"0","summary":"   * Plus Therapeutics Inc    预计将在11月4日公布截至2024年9月30日的业绩报告。* 根据LSEG的数据，3位分析师的平均预期显示，这家总部位于德克萨斯州奥斯汀的公司的营收预计将从去年同期的124万美元增长22.3%，达到151.7万美元。* LSEG 分析师对 Plus Therapeutics Inc 的平均预期是每股亏损 56 美分。* 华尔街对 Plus Therapeutics Inc 的 12 个月目标价中位数为 32.00 美元，高于其上次收盘价 1.35 美元。11月2日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","PSTV"],"gpt_icon":0},{"id":"2478166558","title":"Plus Therapeutics Inc   预计每股亏损56美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2478166558","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478166558?lang=zh_cn&edition=full","pubTime":"2024-10-27 22:51","pubTimestamp":1730040693,"startTime":"0","endTime":"0","summary":"   * Plus Therapeutics Inc    预计将在10月29日公布截至2024年9月30日的业绩报告。* 根据LSEG的数据，3位分析师的平均预期显示，这家总部位于德克萨斯州奥斯汀的公司的营收预计将从去年同期的124万美元增长22.3%，达到151.7万美元。* LSEG 分析师对 Plus Therapeutics Inc 的平均预期是每股亏损 56 美分。* 华尔街对 Plus Therapeutics Inc 的 12 个月目标价中位数为 32.00 美元，高于其最新收盘价 1.35 美元。10月27日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSTV","LENZ"],"gpt_icon":0},{"id":"2475630837","title":"Plus Therapeutics, Inc.盘中异动 股价大涨5.30%报1.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475630837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475630837?lang=zh_cn&edition=full","pubTime":"2024-10-16 00:30","pubTimestamp":1729009841,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日00时30分，Plus Therapeutics, Inc.股票出现波动，股价大幅拉升5.30%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.65%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016003042a1e0dc5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016003042a1e0dc5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTVZ","LENZ","PSTV","BK4139"],"gpt_icon":0},{"id":"2474722502","title":"Plus Therapeutics, Inc.盘中异动 快速下挫5.88%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474722502","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474722502?lang=zh_cn&edition=full","pubTime":"2024-10-11 01:01","pubTimestamp":1728579695,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日01时01分，Plus Therapeutics, Inc.股票出现波动，股价快速下挫5.88%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011010135a1dfbd84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011010135a1dfbd84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTVZ","PSTV","BK4139","LENZ"],"gpt_icon":0},{"id":"2473472970","title":"Plus Therapeutics, Inc.盘中异动 快速下挫6.01%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473472970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473472970?lang=zh_cn&edition=full","pubTime":"2024-10-08 23:16","pubTimestamp":1728400572,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日23时16分，Plus Therapeutics, Inc.股票出现异动，股价大幅跳水6.01%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Bio-Path Holdings, Inc.、Oculis Holding Ag C/Wts 06/03/2028 、Capricor Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Bio-Path Holdings, Inc.、Gri Bio, Inc.较为活跃，换手率分别为2336.55%、2252.67%、247.05%，振幅较大的相关个股有Virios Therapeutics, Inc.、Trevena Inc、Bio-Path Holdings, Inc.，振幅分别为46.27%、42.80%、39.93%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100823161298e3b350&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100823161298e3b350&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","PSTV","PSTVZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://plustherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.1417},{"period":"1month","weight":-0.084},{"period":"3month","weight":-0.3354},{"period":"6month","weight":-0.3944},{"period":"1year","weight":-0.4233},{"period":"ytd","weight":-0.3772}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Plus Therapeutics, Inc.该公司于1996年7月作为一家加利福尼亚普通合伙企业而组建，并于1997年5月在特拉华成立。初期，以MacroPore Biosurgery为名而被知晓，在此之前是MacroPore。该公司是一家美国制药公司，开发具有先进平台技术的中枢神经系统（“CNS”）癌症靶向放射治疗药物。该公司的新型放射性药物制剂和治疗候选药物旨在向肿瘤提供安全有效的辐射剂量。为了实现这一点，该公司开发了药物配方的创新方法，包括用纳米脂质体和微球封装铼同位素等放射性核素。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.086805},{"month":2,"riseRate":0.545455,"avgChangeRate":0.039148},{"month":3,"riseRate":0.363636,"avgChangeRate":-0.06084},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.017896},{"month":5,"riseRate":0.5,"avgChangeRate":0.404923},{"month":6,"riseRate":0.217391,"avgChangeRate":-0.089219},{"month":7,"riseRate":0.391304,"avgChangeRate":-0.020953},{"month":8,"riseRate":0.304348,"avgChangeRate":-0.041134},{"month":9,"riseRate":0.521739,"avgChangeRate":-0.053123},{"month":10,"riseRate":0.304348,"avgChangeRate":-0.05654},{"month":11,"riseRate":0.347826,"avgChangeRate":0.002696},{"month":12,"riseRate":0.391304,"avgChangeRate":-0.024391}],"exchange":"NASDAQ","name":"Plus Therapeutics, Inc.","nameEN":"Plus Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Plus Therapeutics, Inc.(PSTV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Plus Therapeutics, Inc.(PSTV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Plus Therapeutics, Inc.,PSTV,Plus Therapeutics, Inc.股票,Plus Therapeutics, Inc.股票老虎,Plus Therapeutics, Inc.股票老虎国际,Plus Therapeutics, Inc.行情,Plus Therapeutics, Inc.股票行情,Plus Therapeutics, Inc.股价,Plus Therapeutics, Inc.股市,Plus Therapeutics, Inc.股票价格,Plus Therapeutics, Inc.股票交易,Plus Therapeutics, Inc.股票购买,Plus Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Plus Therapeutics, Inc.(PSTV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Plus Therapeutics, Inc.(PSTV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}